Balance Sheet
Cash Flow Statement
Daily Values
DMA 100DMA 200DMA 50Dividend YieldEV to CFOEV to EBITEV to EBITDAEV to FCFEV to RevenueEnterprise ValueMarket Cap to FCFMarket CapitalizationPricePrice to EarningsPrice to Sales
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Orthofix Medical (OFIX) Enterprise Value (2016 - 2026)

Orthofix Medical has reported Enterprise Value over the past 18 years, most recently at -$120.9 million for Q1 2026.

  • For the quarter ending Q1 2026, Enterprise Value fell 99.94% year-over-year to -$120.9 million, compared with a TTM value of -$120.9 million through Mar 2026, down 99.94%, and an annual FY2025 reading of -$85.1 million, up 0.73% over the prior year.
  • Enterprise Value came in at -$120.9 million for Q1 2026, down from -$85.1 million in the prior quarter.
  • In the past five years, Enterprise Value ranged from a high of -$28.9 million in Q2 2024 to a low of -$120.9 million in Q1 2026.
  • Median Enterprise Value over the past 5 years was -$51.7 million (2022), compared with a mean of -$57.1 million.
  • The sharpest move saw Enterprise Value soared 42.29% in 2022, then plummeted 137.96% in 2025.
  • Over 5 years, Enterprise Value stood at -$50.7 million in 2022, then grew by 25.53% to -$37.8 million in 2023, then plummeted by 127.08% to -$85.7 million in 2024, then grew by 0.73% to -$85.1 million in 2025, then tumbled by 42.01% to -$120.9 million in 2026.
  • Per Business Quant, the three most recent readings for OFIX's Enterprise Value are -$120.9 million (Q1 2026), -$85.1 million (Q4 2025), and -$65.9 million (Q3 2025).